Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday

Author: Avi Kapoor | September 05, 2024 08:19am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Piper Sandler cut the price target for C3.ai, Inc. (NYSE:AI) from $29 to $24. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. C3.ai shares fell 1.9% to close at $23.01 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. raised the price target for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) from $47 to $50. HC Wainwright & Co. analyst Oren Livnat maintained a Buy rating. Praxis Collegium Pharmaceutical shares gained 2.2% to close at $38.24 on Wednesday. See how other analysts view this stock.
  • Needham cut ChargePoint Holdings, Inc. (NYSE:CHPT) price target from $3 to $2. Needham analyst Chris Pierce maintained a Buy rating. ChargePoint shares fell 0.6% to close at $1.69 on Wednesday. See how other analysts view this stock.
  • Morgan Stanley raised S&P Global Inc. (NYSE:SPGI) price target from $530 to $564. Morgan Stanley analyst Toni Kaplan maintained an Overweight rating. S&P Global shares gained 0.5% to close at $513.31 on Wednesday. See how other analysts view this stock.
  • BMO Capital cut the price target for Dollar Tree, Inc. (NASDAQ:DLTR) from $130 to $68. BMO Capital analyst Kelly Bania downgraded the stock from Outperform to Market Perform. Dollar Tree shares fell 22.2% to close at $63.56 on Wednesday. See how other analysts view this stock.
  • Goldman Sachs raised Novartis AG (NYSE:NVS) price target from $119 to $121. Goldman Sachs analyst James Quigley downgraded the stock from Buy to Neutral. Novartis shares rose 0.7% to close at $119.38 on Wednesday. See how other analysts view this stock.
  • Baird cut Core & Main, Inc. (NYSE:CNM) price target from $62 to $53. Baird analyst David Manthey maintained an Outperform rating. Core & Main shares fell 15.8% to close at $39.40 on Wednesday. See how other analysts view this stock.
  • Susquehanna slashed the price target for EVERTEC, Inc. (NYSE:EVTC) from $38 to $28. Susquehanna analyst James Friedman downgraded the stock from Neutral to Negative. EVERTEC shares rose 0.3% to close at $33.73 on Wednesday. See how other analysts view this stock.
  • Piper Sandler cut Celanese Corporation (NYSE:CE) price target from $180 to $150. Piper Sandler analyst Charles Neivert downgraded the stock from Overweight to Neutral. Celanese shares fell 0.8% to close at $124.31 on Wednesday. See how other analysts view this stock.
  • Morgan Stanley lowered StoneCo Ltd. (NASDAQ:STNE) price target from $16.5 to $7. Morgan Stanley analyst Jorge Kuri downgraded the stock from Equal-Weight to Underweight. StoneCo shares fell 3.8% to close at $12.61 on Wednesday. See how other analysts view this stock.

Considering buying SPGI stock? Here’s what analysts think:

Posted In: AI CE CHPT CNM COLL DLTR EVTC NVS SPGI STNE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist